Number of the records: 1  

XIII. Výročný kongres Medzinárodnej spoločnosti pre farmakoekonomiku a výskum výsledkov. Toronto, 3.-7.V.2008

  1. TitleXIII. Výročný kongres Medzinárodnej spoločnosti pre farmakoekonomiku a výskum výsledkov. Toronto, 3.-7.V.2008
    Document partČasť 3.. Psychiatria
    Author infoVeronika Dubajová, Lenka Petrová, Viliam Foltán
    Author Dubajová Veronika
    Co-authors Petrová Lenka
    Foltán Viliam 1946-
    NoteVoľný preklad z kongresových materiálov
    Sign.C 3079
    Source Farmakoekonomika a lieková politika : oficiálny časopis Slovenskej spoločnosti pre farmakoekonomiku. - ISSN 1336-7021. - Nové Mesto nad Váhom : TISING , 2008 . - Roč. 4, č. 4 (2008), s. 32-34 a 36-40  : ilustr. (fareb.), obr.
    Contains alsoRehospitalization after discontinuation of paliperidone ER in patients with schizoprenia / J. Wu a kol. -- The prevalence and costs of metabolic conditions among patients with bipolar disorders compared with matched controls / Tami L. Mark a kol. -- Mental healthcare resource use before and after initiation of paliperidone ER in patients with schizophrenia / J. Wu a kol. -- Costs of non-compliance with antipsychotic medications among patients with schizophrenia / Salas M. a kol. -- Acamprosate in treatment of alcohol dependence - economic benefits revisited / M. Haim Erder a kol. -- Predictors of medication adherence among patients with schizophrenic disorders treated with typical and atypical antipsychotics in a large state medicaid program / S. P. Lee a kol. -- Cost of psychiatric hospitalizations in the United States in 2006 / Michael D. Stensland a kol. -- Health care resource utilization and costs comparison for MDD patients on 10 mg escitalopram who increased to 20 mg dose versus those who were switched to SNRI / Eric Q. Wu a kol. -- Impact of risperidone long-acting injection versus oral antipsychotic treatments on hospitalization in schizophrenia / J. M. Olivares a kol. -- Treatment outcomes of Risperidone Long Acting Injection (RLAI) in schizophrenia: 18-month results from the electronic schizophrenia treatment adherence registry (e-STAR) in Czech Republic and Slovakia -- Clinical and functional improvements in patients with schizophrenia treated with risperidone long acting lnjection: Interim results from observational studies conducted in Australia, Belgium and the United States -- Improved work productivity in the United States (US) for patients treated with escitalopram compared to duloxetine / Francois C. a kol. -- Economic assessment of three commonly used antipsychotic agents in the public sector of hong kong using a decision analytic model / Lee K. K. C. a kol. -- Retention rates for oral and depot antipsychotic medications over one year in Ontario, Canada / Glass Jennifer a kol.
    Event keywords International Society for Pharmacoeconomics and Outcomes Research. Annual international meeting ( 13. : 2008 : Toronto, Kanada )
    MeSH Subject farmakoekonomika
    poruchy duševné : ekonomika
    náklady a analýza nákladov
    náklady na ochorenie
    náklady na zdravotnú starostlivosť
    Extended TitleTrinásty Výročný kongres Medzinárodnej spoločnosti pre farmakoekonomiku a výskum výsledkov. Toronto, 3.-7.V.2008
    LanguageSlovak
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.